AI in Brief — Thursday, 24 September 2026

Enveda, an AI biotech firm, raised $311m in funding, valuing the company at $2 billion. The round will support clinical trials for nature-derived drugs developed with AI, including treatments for skin conditions and weight-loss preservation after patients stop taking GLP-1 medications. Source

Ema, an enterprise software firm using AI, raised $77m in new funding and has received $140m to date. The company counts more than 50 enterprise customers, including Google and Microsoft, as AI tools increasingly displace traditional business software and services. Source

Anthropic's artificial intelligence model Claude has "autonomously discovered" a new enzyme system at the company's biological research lab that the firm compares to machinery behind the gene-editing tool Crispr. The discovery marks the first result from Anthropic's newly launched wet lab, though humans remain in the loop overseeing Claude's work. Source

Mark Zuckerberg, Meta's chief executive, unveiled expansions to Muse, the company's AI agent, at Meta Connect in Menlo Park on Wednesday. Muse is being integrated into Meta's smart glasses and gaining new capabilities including the ability to receive email addresses for task completion and conduct video chats with users. Source

Meta unveiled camera-free smart glasses at Connect, departing from earlier models equipped with cameras. The new glasses will be lighter than previous versions and offer up to 12 hours of battery life, addressing public concerns over wearable surveillance technology. Source

Cookie Consent with Real Cookie Banner